News - RegMed XB | Regenerative Medicine Crossing Borders - Results from #24

Skip to main content

Letter of Commitment Signed

15 Nov 2018

Read more
New pro-bono collaboration with Trailblazers

05 Jun 2020

Read more
FIRST participates in 1.8 million seed investment for the discovery of two new drugs for heart failure

20 Jan 2022

Read more
RegMed XB in De Limburger (in Dutch)

01 Sep 2016

Read more
Next building block for cartilage production

03 Feb 2021

Read more
More advances in research on kidney organoids

21 Jul 2020

Read more
High potential of renal organoids and tubuloids in the treatment of kidney diseases

20 Jul 2020

Read more
Day two: First Townhall meeting RegMed XB successful!

19 Mar 2021

Read more
Vlaamse regering investeert 15 miljoen euro in RegMed XB voor regeneratieve therapieën

16 Jan 2024

Read more
Insights from the EU-Japan Biotech & Pharma Partnering Conference 2023

24 Oct 2023

Read more
RegMed XB press release

06 Jun 2016

Read more
An ex vivo human osteochondral culture model

07 Oct 2020

Read more
Smart Biomaterials Consortium is on a roll!

06 Dec 2022

Read more
56 million euros from National Growth Fund

09 Apr 2021

Read more
RegMed XB Researchers build mini-kidneys from urinary cells

04 Mar 2019

Read more
Medical Scientific Director RegMed XB speaks at ISCT Annual Meeting

02 Jun 2023

Read more
RegMed XB Pilotfabriek opent deuren voor Nationaal Groeifonds commissie

22 Dec 2022

Read more
Bernard Mulder (Algemeen Directeur RegMed XB) te gast in de Leaders in Life Sciences Podcast

24 Jan 2023

Read more
De tijd van Marianne van der Steen bij RegMed XB

28 Nov 2023

Read more
Registration is open now

01 Mar 2024

Read more
The BioLIVE and Pharma IT & Digital Health Expo

22 Feb 2022

Read more
A first step towards personalized prediction of thrombus formation risk and thromboembolism with regard to ex-vivo perfusion of organs such as the heart.

25 Feb 2022

Read more
One step closer to therapies based on cartilage regeneration

18 Nov 2020

Read more
RegMed XB 2022 Annual Meeting

14 Jul 2022

Read more
ReGEN Biomedical and Demcon Announce New Partnership

05 Feb 2024

Read more
August Newsletter

30 Aug 2017

Read more
The Influence of OAT1 Density and Functionality on Indoxyl Sulfate Transport in the Human Proximal Tubule

05 Oct 2021

Read more
RegMed XB 2020 Annual Meeting

11 Mar 2020

Read more
SBMC invests 4 million euro in New Pilot Production Facility for biomaterials

27 Sep 2023

Read more
Automation Entrepreneurs Receive Regional Subsidy

07 Aug 2018

Read more
Update: International Conference of Tissue-Engineered Heart Valves

23 Apr 2018

Read more
Highlights from the RegMed XB 1st Annual Conference

10 Jul 2023

Read more
Why Definitions Matter and Why We May Need One for Embryo-Like Structures

28 Apr 2021

Read more
Over 170 Participants Gather in Leuven for the Inaugural Advanced Therapies Summit on October 19th

17 Oct 2023

Read more
Day one: First Townhall meeting RegMed XB successful!

18 Mar 2021

Read more
RegMed XB column in the Dutch patient magazine “Wisselwerking”

30 Oct 2020

Read more
RegMed XB Showcased in Local Newspaper for Successful First Annual Conference on Regenerative Medicine in Leiden

27 Jul 2023

Read more
Doe mee met de Coast to Coast Challenge

06 Mar 2023

Read more
Symposium on Regenerative Medicine in Osaka Japan and online

21 Mar 2023

Read more
Micky Adriaansens, Dutch Minister of Economic Affairs and Climate, visits RegMed XB Pilot Factory

12 Jul 2023

Read more
3rd NanoBio Surfaces and Interfaces in Healthcare and Science Workshop

05 Apr 2018

Read more
Launch of FIRST investment fund

17 Feb 2020

Read more
Geweldig! DON haalt ruim 1,7 miljoen op voor genezing diabetes type 1

03 Oct 2022

Read more
First investment in potential medicine for stroke by FIRST-fund

11 Dec 2020

Read more
33 million euros from National Growth Fund for RegMed XB Pilot factory for regenerative medicine

14 Apr 2022

Read more
Minder proefdierharten nodig voor onderzoek door inzet slachtafval

10 Feb 2023

Read more
RegMed XB start nieuwe moonshot voor hart- en vaatziekten

06 Feb 2019

Read more
Realisation of national Pilot factory for regenerative medicine has started

23 Dec 2021

Read more
Biomedica On The Move

02 Jul 2019

Read more
The Ethics of Synthetic Embryology: A Blessing or a Curse?

02 Dec 2020

Read more

33 million euros from National Growth Fund for RegMed XB Pilot factory for regenerative medicine

33 million euros from National Growth Fund for RegMed XB Pilot factory for regenerative medicine

The urgency is high in the field of regenerative medicine. Promising therapies are in the pipeline from the lab to the patient, but a good infrastructure is needed to make this possible.

A first step towards personalized prediction of thrombus formation risk and thromboembolism with regard to ex-vivo perfusion of organs such as the heart.

A first step towards personalized prediction of thrombus formation risk and thromboembolism with regard to ex-vivo perfusion of organs such as the heart.

Mohammad Rezaeimoghaddam and Frans van de Vosse have published a paper with the title ”Continuum modeling of thrombus formation and growth under different shear rates” in the Journal of Biomechanics.

The BioLIVE and Pharma IT & Digital Health Expo

The BioLIVE and Pharma IT & Digital Health Expo

Interested in showcasing your BioPharma or Digital Health technologies to the Japanese audience?

FIRST participates in 1.8 million seed investment for the discovery of two new drugs for heart failure

FIRST participates in 1.8 million seed investment for the discovery of two new drugs for heart failure

River BioMedics, a drug discovery company using advanced 3D human cardiac models, today announced the closure of a 1.8 million Euro seed funding round to progress its research and innovation programs for cardiovascular disease targets and compounds.

Realisation of national Pilot factory for regenerative medicine has started

Realisation of national Pilot factory for regenerative medicine has started

RegMed XB has received the first subsidy of 23 million euros from the Ministry of Economic Affairs and Climate Policy. This is the start of the realization of the national pilot factory for regenerative medicine after the Dutch cabinet decided on 9 April this year to fund the National Growth Fund proposal of RegMed XB.

RegMed XB partner LUMC receives 100 million euros for research for stem cell based therapies

RegMed XB partner LUMC receives 100 million euros for research for stem cell based therapies

Leiden University Medical Centre (LUMC), the DanStem Institute at the University of Copenhagen and the Murdoch Children's Research Institute in Melbourne will jointly receive 300 million euros from the Novo Nordisk Foundation.

1
2
3
4
5
6
7
8
…
12

If you want to stay ahead of RegMed XB and all the things we do
subscribe to our newsletter to stay informed of the latest developments.

Have something to share?

Now you can contribute to keep our news section fresh and up-to date with relevant events and grants, research results and high impact publications related to REGMED XB’ Moonshots. Contributions can be sent to This email address is being protected from spambots. You need JavaScript enabled to view it.. Please submit the text in English and include a short title. We are looking forward to your input!